SynBioBeta’s 2018 Q2 funding update: The last quarter saw the biggest funding for synthetic biology for any three-month period in history.
The year started on a record-setting pace, with 27 synthetic biology companies raising $650 million in private and public funding in Q1. That was twice the amount raised in the same period last year. Then Q2 came along and beat it in every metric: 33 companies raised $925 million, up by a factor of 4 from last year.